首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   45篇
  免费   1篇
  4篇
综合类   6篇
农作物   31篇
水产渔业   5篇
  2021年   6篇
  2020年   5篇
  2019年   2篇
  2018年   2篇
  2017年   1篇
  2016年   3篇
  2015年   8篇
  2014年   5篇
  2013年   3篇
  2012年   4篇
  2011年   2篇
  2009年   1篇
  2007年   2篇
  2005年   1篇
  2004年   1篇
排序方式: 共有46条查询结果,搜索用时 5 毫秒
1.
为阐明氮元素对微藻次生代谢积累和调控的影响,以三角褐指藻为试验材料,研究不同氮浓度[896(CK)、448、112、28和0 μmol·L-1]处理对三角褐指藻细胞生长、岩藻黄素含量、油脂含量以及叶绿素a含量的影响,并对岩藻黄素-叶绿素蛋白复合体基因(FCPb)和酰基-酰基载体蛋白去饱和酶基因(FAB2)的表达进行实时荧光定量PCR分析。结果表明,氮限制极显著抑制了三角褐指藻细胞的生长和岩藻黄素的合成,但促进了油脂的合成。当氮浓度为112 μmol·L-1时,三角褐指藻岩藻黄素含量最低(0.084 mg·g-1DW),而油脂含量最高,较CK提高了1.36倍。叶绿素a与岩藻黄素含量变化趋势一致。相关性分析表明,氮限制条件下,三角褐指藻岩藻黄素含量与油脂含量显著相关(R2=0.998 8)。实时荧光定量PCR分析表明,氮限制抑制了三角褐指藻中FCPb的表达,促进了FAB2的表达。综上,氮限制通过调控三角褐指藻岩藻黄素、油脂生物合成途径相关基因的表达影响了岩藻黄素和油脂的积累。本研究为进一步探究岩藻黄素与脂类物质代谢合成的关联性提供了一定的理论参考。  相似文献   
2.
Two-level full factorial design was employed to identify the extraction parameters that can improve the derivation of fucoxanthin content (FC), total carotenoid content (TCC), and antioxidant from two brown seaweeds, Sargassum siliquosum (SS) and Sargassum polycystum (SP). These parameters included temperature (A: 4–45°C), time (B: 30–1,440 min), and solvent-to-solid ratio (C: 10–50 ml/g). Antioxidant activities were determined as trolox equivalent antioxidant capacity (TEAC), 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity, and ferric-reducing antioxidant power (FRAP). Results showed that all three factors were significant (p < 0.05) in providing higher FC in both species. These factors were also significant in obtaining higher TCC in SS; whereas in SP, TCC was only affected by solvent-to-solid ratio. Only temperature was found to contribute significantly to a higher TEAC in both species. However, none of the factors improved DPPH for SS, except temperature and time for SP. For SS, only time was significant in obtaining higher FRAP; whereas temperature and time were significant for SP. Hence, results indicate that a simple modification in the extraction temperature, time, and solvent-to-solid ratio will be able to improve the derivation of fucoxanthin, carotenoids, and antioxidant activities.  相似文献   
3.
The mechanism for how fucoxanthin (FX) suppressed adipose accumulation is unclear. We aim to investigate the effects of FX on metabolic rate and expressions of genes related to thermogenesis, mitochondria biogenesis and homeostasis. Using a 2 × 2 factorial design, four groups of mice were respectively fed a high sucrose (50% sucrose) or a high-fat diet (23% butter + 7% soybean oil) supplemented with or without 0.2% FX. FX significantly increased oxygen consumption and carbon dioxide production and reduced white adipose tissue (WAT) mass. The mRNA expressions of peroxisome proliferator-activated receptor (PPAR) γ coactivator-1α (PGC-1α), cell death-inducing DFFA-like effecter a (CIDEA), PPARα, PPARγ, estrogen-related receptor α (ERRα), β3-adrenergic receptor (β3-AR) and deiodinase 2 (Dio2) were significantly upregulated in inguinal WAT (iWAT) and epididymal WAT (eWAT) by FX. Mitochondrial biogenic genes, nuclear respiratory factor 1 (NRF1) and NRF2, were increased in eWAT by FX. Noticeably, FX upregulated genes of mitochondrial fusion, mitofusin 1 (Mfn1), Mfn2 and optic atrophy 1 (OPA1), but not mitochondrial fission, Fission 1, in both iWAT and eWAT. In conclusion, dietary FX enhanced the metabolic rate and lowered adipose mass irrespective of the diet. These were associated with upregulated genes of the PGC-1α network and mitochondrial fusion in eWAT and iWAT.  相似文献   
4.
Luc J. Martin 《Marine drugs》2015,13(8):4784-4798
Fucoxanthin is a carotenoid present in the chloroplasts of brown seaweeds. When ingested, it is metabolized mainly to fucoxanthinol by digestive enzymes of the gastrointestinal tract. These compounds have been shown to have many beneficial health effects, including anti-mutagenic, anti-diabetic, anti-obesity, anti-inflammatory and anti-neoplastic actions. In every cancer tested, modulatory actions of fucoxanthinol on viability, cell-cycle arrest, apoptosis and members of the NF-κB pathway were more pronounced than that of fucoxanthin. Anti-proliferative and cancer preventing influences of fucoxanthin and fucoxanthinol are mediated through different signalling pathways, including the caspases, Bcl-2 proteins, MAPK, PI3K/Akt, JAK/STAT, AP-1, GADD45, and several other molecules that are involved in cell cycle arrest, apoptosis, anti-angiogenesis or inhibition of metastasis. In this review, we address the mechanisms of action of fucoxanthin and fucoxanthinol according to different types of cancers. Current findings suggest that these compounds could be effective for treatment and/or prevention of cancer development and aggressiveness.  相似文献   
5.
海带岩藻黄素对小鼠脂质过氧化抑制作用的影响   总被引:1,自引:0,他引:1  
用硫代巴比妥酸法测定小鼠肝组织及线粒体中丙二醛的含量,用分光光度法测定小鼠红细胞溶血和肝线粒体的肿胀程度,从而考察海带Laminaria japonica岩藻黄素对小鼠脂质体系的抗氧化能力。结果表明:岩藻黄素能在自发和诱导条件下抑制肝匀浆液及线粒体中丙二醛的产生,降低红细胞的溶血程度,并能减轻肝线粒体的肿胀程度,且其抑制作用均呈明显的剂量效应关系。这说明海带岩藻黄素具有明显的抗氧化作用。  相似文献   
6.
Fucoxanthin, a natural carotenoid abundant in edible brown seaweeds, has been shown to possess anti-cancer, anti-oxidant, anti-obesity and anti-diabetic effects. In this study, we report for the first time that fucoxanthin effectively protects against scopolamine-induced cognitive impairments in mice. In addition, fucoxanthin significantly reversed the scopolamine-induced increase of acetylcholinesterase (AChE) activity and decreased both choline acetyltransferase activity and brain-derived neurotrophic factor (BDNF) expression. Using an in vitro AChE activity assay, we discovered that fucoxanthin directly inhibits AChE with an IC50 value of 81.2 μM. Molecular docking analysis suggests that fucoxanthin likely interacts with the peripheral anionic site within AChE, which is in accordance with enzymatic activity results showing that fucoxanthin inhibits AChE in a non-competitive manner. Based on our current findings, we anticipate that fucoxanthin might exhibit great therapeutic efficacy for the treatment of Alzheimer’s disease by acting on multiple targets, including inhibiting AChE and increasing BDNF expression.  相似文献   
7.
Epidemiological studies have shown a relation between antioxidants and the prevention of several chronic diseases. Microalgae are a potential novel source of bioactive molecules, including a wide range of different carotenoids that can be used as nutraceuticals, food supplements and novel food products. The objective of this review is (i) to update the research that has been carried out on the most known carotenoids produced by marine microalgae, including reporting on their high potentialities to produce other less known important compounds; (ii) to compile the work that has been done in order to establish some relationship between carotenoids and oxidative protection and treatment; (iii) to summarize the association of oxidative stress and the various reactive species including free radicals with several human diseases; and (iv) to provide evidence of the potential of carotenoids from marine microalgae to be used as therapeutics to treat or prevent these oxidative stress-related diseases.  相似文献   
8.
Cardiovascular diseases such as atherosclerosis and aortic valve sclerosis involve inflammatory reactions triggered by various stimuli, causing increased oxidative stress. This increased oxidative stress causes damage to the heart cells, with subsequent cell apoptosis or calcification. Currently, heart valve damage or heart valve diseases are treated by drugs or surgery. Natural antioxidant products are being investigated in related research, such as fucoxanthin (Fx), which is a marine carotenoid extracted from seaweed, with strong antioxidant, anti-inflammatory, and anti-tumor properties. This study aimed to explore the protective effect of Fx on heart valves under high oxidative stress, as well as the underlying mechanism of action. Rat heart valve interstitial cells under H2O2-induced oxidative stress were treated with Fx. Fx improved cell survival and reduced oxidative stress-induced DNA damage, which was assessed by cell viability analysis and staining with propidium iodide. Alizarin Red-S analysis indicated that Fx has a protective effect against calcification. Furthermore, Western blotting revealed that Fx abrogates oxidative stress-induced apoptosis via reducing the expression of apoptosis-related proteins as well as modulate Akt/ERK-related protein expression. Notably, in vivo experiments using 26 dogs treated with 60 mg/kg of Fx in combination with medical treatment for 0.5 to 2 years showed significant recovery in their echocardiographic parameters. Collectively, these in vitro and in vivo results highlight the potential of Fx to protect heart valve cells from high oxidative stress-induced damage.  相似文献   
9.
褐藻素-叶绿素a/c结合蛋白(FCP)由核基因家族编码,镶嵌在杂色藻类的类囊体膜中,结合褐藻素、叶绿素a和叶绿素c,起着捕获并向两个光反应中心平均分配和传递光能的作用。前体N-末端存在一个信号肽和一个转运肽,成熟FCP具3个α-螺旋跨膜区,分子量在17~22kDa之间,结合叶绿素a的氨基酸高度保守,但结合褐藻素和叶绿素c的不太保守。fcp基因一般存在一个内含子,其蛋白编码区同源性达80%以上,而5’和3’非翻译区保守性相对较低。励基因表达量在红光及相对强光强下一般较高,且可能还存在日周变化.具4个α-螺旋的叶绿素a/b结合蛋白的第4个α-螺旋区缺失可能导致了具3个α-螺旋的FCP的产生。  相似文献   
10.
Peng J  Yuan JP  Wu CF  Wang JH 《Marine drugs》2011,9(10):1806-1828
The marine carotenoid fucoxanthin can be found in marine brown seaweeds, the macroalgae, and diatoms, the microalgae, and has remarkable biological properties. Numerous studies have shown that fucoxanthin has considerable potential and promising applications in human health. In this article, we review the current available scientific literature regarding the metabolism, safety, and bioactivities of fucoxanthin, including its antioxidant, anti-inflammatory, anticancer, anti-obese, antidiabetic, antiangiogenic and antimalarial activities, and its protective effects on the liver, blood vessels of the brain, bones, skin, and eyes. Although some studies have shown the bioavailability of fucoxanthin in brown seaweeds to be low in humans, many studies have suggested that a dietary combination of fucoxanthin and edible oil or lipid could increase the absorption rate of fucoxanthin, and thus it might be a promising marine drug.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号